Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2007 (2007), Article ID 52040, 7 pages
http://dx.doi.org/10.1155/2007/52040
Research Article

Soluble Triggering Receptor Expressed on Myeloid Cells 1 Is Released in Patients with Stable Chronic Obstructive Pulmonary Disease

1Institute of Immunology, University of Mainz, Obere Zahlbacher Street 67, Mainz 55131, Germany
2III Medical Clinic, University of Mainz, Langenbeck Street 1, Mainz 55101, Germany
3University Medical Hospital, Department of Medicine II, University of Tübingen, Otfried-Müller-Street 10, Tübingen 72076, Germany

Received 13 June 2007; Accepted 13 August 2007

Academic Editor: Kurt Blaser

Copyright © 2007 Markus P. Radsak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. F. Murphy, “The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease,” Current Opinion in Infectious Diseases, vol. 19, no. 3, pp. 225–230, 2006. View at Publisher · View at Google Scholar
  2. P. Mallia and S. L. Johnston, “Mechanisms and experimental models of chronic obstructive pulmonary exacerbations,” Proceedings of the American Thoracic Society, vol. 2, no. 4, pp. 361–366, 2005. View at Publisher · View at Google Scholar
  3. S. Sethi, “Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease,” Seminars in Respiratory and Critical Care Medicine, vol. 26, no. 2, pp. 192–203, 2005. View at Publisher · View at Google Scholar
  4. W. Q. Gan, S. F. P. Man, A. Senthilselvan, and D. D. Sin, “Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis,” Thorax, vol. 59, no. 7, pp. 574–580, 2004. View at Publisher · View at Google Scholar
  5. A. G. N. Agustí, “Systemic effects of chronic obstructive pulmonary disease,” Proceedings of the American Thoracic Society, vol. 2, no. 4, pp. 367–370, 2005. View at Publisher · View at Google Scholar
  6. A. T. Hill, E. J. Campbell, S. L. Hill, D. L. Bayley, and R. A. Stockley, “Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis,” The American Journal of Medicine, vol. 109, no. 4, pp. 288–295, 2000. View at Publisher · View at Google Scholar
  7. R. A. Stockley, A. T. Hill, S. L. Hill, and E. J. Campbell, “Bronchial inflammation: its relationship to colonizing microbial load and α1-antitrypsin deficiency,” Chest, vol. 117, no. 5, supplment 1, pp. 291S–293S, 2000. View at Publisher · View at Google Scholar
  8. N. Soler, S. Ewig, A. Torres, X. Filella, J. Gonzalez, and A. Zaubet, “Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 14, no. 5, pp. 1015–1022, 1999. View at Google Scholar
  9. S. Sethi, K. Muscarella, N. Evans, K. L. Klingman, B. J. B. Grant, and T. F. Murphy, “Airway inflammation and etiology of acute exacerbations of chronic bronchitis,” Chest, vol. 118, no. 6, pp. 1557–1565, 2000. View at Publisher · View at Google Scholar
  10. D. Banerjee, O. A. Khair, and D. Honeybourne, “Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD,” European Respiratory Journal, vol. 23, no. 5, pp. 685–691, 2004. View at Google Scholar
  11. A. Bouchon, J. Dietrich, and M. Colonna, “Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes,” Journal of Immunology, vol. 164, no. 10, pp. 4991–4995, 2000. View at Google Scholar
  12. M. Schenk, A. Bouchon, S. Birrer, M. Colonna, and C. Mueller, “Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine,” Journal of Immunology, vol. 174, no. 1, pp. 517–524, 2005. View at Google Scholar
  13. M. P. Radsak, H. R. Salih, H.-G. Rammensee, and H. Schild, “Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival,” Journal of Immunology, vol. 172, no. 8, pp. 4956–4963, 2004. View at Google Scholar
  14. P. Haselmayer, L. Grosse-Hovest, P. von Landenberg, H. Schild, and M. P. Radsak, “TREM-1 ligand expression on platelets enhances neutrophil activation,” Blood, vol. 110, no. 3, pp. 1029–1035, 2007. View at Publisher · View at Google Scholar
  15. A. Bouchon, F. Facchetti, M. A. Weigand, and M. Colonna, “TREM-1 amplifies inflammation and is a crucial mediator of septic shock,” Nature, vol. 410, no. 6832, pp. 1103–1107, 2001. View at Publisher · View at Google Scholar
  16. S. Gibot, M.-N. Kolopp-Sarda, M.-C. Béné et al., “A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis,” Journal of Experimental Medicine, vol. 200, no. 11, pp. 1419–1426, 2004. View at Publisher · View at Google Scholar
  17. S. Gibot, C. Buonsanti, F. Massin et al., “Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock,” Infection and Immunity, vol. 74, no. 5, pp. 2823–2830, 2006. View at Publisher · View at Google Scholar
  18. M.-C. Gingras, H. Lapillonne, and J. F. Margolin, “TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development,” Molecular Immunology, vol. 38, no. 11, pp. 817–824, 2002. View at Publisher · View at Google Scholar
  19. S. Knapp, S. Gibot, A. de Vos, H. H. Versteeg, M. Colonna, and T. van der Poll, “Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia,” Journal of Immunology, vol. 173, no. 12, pp. 7131–7134, 2004. View at Google Scholar
  20. S. Gibot, A. Cravoisy, B. Levy, M.-C. Bene, G. Faure, and P.-E. Bollaert, “Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia,” The New England Journal of Medicine, vol. 350, no. 5, pp. 451–458, 2004. View at Publisher · View at Google Scholar
  21. S. Gibot, “Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis,” Critical Care, vol. 9, no. 5, pp. 485–489, 2005. View at Publisher · View at Google Scholar
  22. S. Gibot, M.-N. Kolopp-Sarda, M. C. Béné et al., “Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis,” Annals of Internal Medicine, vol. 141, no. 1, pp. 9–15, 2004. View at Google Scholar
  23. S. Gibot, “Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia and severe sepsis,” Seminars in Respiratory and Critical Care Medicine, vol. 27, no. 1, pp. 29–33, 2006. View at Publisher · View at Google Scholar
  24. R. M. Determann, J. L. Millo, S. Gibot et al., “Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia,” Intensive Care Medicine, vol. 31, no. 11, pp. 1495–1500, 2005. View at Publisher · View at Google Scholar
  25. S. Gibot, A. Cravoisy, M.-N. Kolopp-Sarda et al., “Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis,” Critical Care Medicine, vol. 33, no. 4, pp. 792–796, 2005. View at Publisher · View at Google Scholar
  26. L. Richeldi, M. Mariani, M. Losi et al., “Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections,” European Respiratory Journal, vol. 24, no. 2, pp. 247–250, 2004. View at Google Scholar
  27. V. Koussoulas, S. Vassiliou, M. Demonakou et al., “Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease,” European Journal of Gastroenterology & Hepatology, vol. 18, no. 4, pp. 375–379, 2006. View at Publisher · View at Google Scholar
  28. A. M. Mahdy, D. A. Lowes, H. F. Galley, J. E. Bruce, and N. R. Webster, “Production of soluble triggering receptor expressed on myeloid cells by lipopolysaccharide-stimulated human neutrophils involves de novo protein synthesis,” Clinical and Vaccine Immunology, vol. 13, no. 4, pp. 492–495, 2006. View at Publisher · View at Google Scholar
  29. N. MacIntyre, R. O. Crapo, G. Viegi et al., “Standardisation of the single-breath determination of carbon monoxide uptake in the lung,” European Respiratory Journal, vol. 26, no. 4, pp. 720–735, 2005. View at Publisher · View at Google Scholar
  30. M. R. Miller, J. Hankinson, V. Brusasco et al., “Standardisation of spirometry,” European Respiratory Journal, vol. 26, no. 2, pp. 319–338, 2005. View at Publisher · View at Google Scholar
  31. J. Wanger, J. L. Clausen, A. Coates et al., “Standardisation of the measurement of lung volumes,” European Respiratory Journal, vol. 26, no. 3, pp. 511–522, 2005. View at Publisher · View at Google Scholar
  32. R. A. Pauwels, A. S. Buist, P. M. A. Calverley, C. R. Jenkins, and S. S. Hurd, “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 5, pp. 1256–1276, 2001. View at Google Scholar
  33. J. C. Hogg, F. Chu, S. Utokaparch et al., “The nature of small-airway obstruction in chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 350, no. 26, pp. 2645–2653, 2004. View at Publisher · View at Google Scholar
  34. D. G. Parr, A. J. White, D. L. Bayley, P. J. Guest, and R. A. Stockley, “Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study,” Respiratory Research, vol. 7, p. 136, 2006. View at Publisher · View at Google Scholar
  35. J. Sauleda, F. J. García-Palmer, G. González, A. Palou, and A. G. N. Agustí, “The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease, asthma, and chronic arthritis,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 1, pp. 32–35, 2000. View at Google Scholar
  36. S. A. Lewis, I. D. Pavord, J. R. Stringer, A. J. Knox, S. T. Weiss, and J. R. Britton, “The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults,” Chest, vol. 119, no. 1, pp. 105–114, 2001. View at Publisher · View at Google Scholar
  37. D. Burnett, S. L. Hill, A. Chamba, and R. A. Stockley, “Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis,” The Lancet, vol. 330, no. 8567, pp. 1043–1046, 1987. View at Publisher · View at Google Scholar
  38. A. Noguera, S. Batle, C. Miralles et al., “Enhanced neutrophil response in chronic obstructive pulmonary disease,” Thorax, vol. 56, no. 6, pp. 432–437, 2001. View at Publisher · View at Google Scholar
  39. A. Noguera, X. Busquets, J. Sauleda, J. M. Villaverde, W. MacNee, and A. G. N. Agustí, “Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 5, part 1, pp. 1664–1668, 1998. View at Google Scholar
  40. P. M. O'byrne and D. S. Postma, “The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 5, part 2, pp. S41–63, 1999. View at Google Scholar
  41. J. Phua, E. S. C. Koay, D. Zhang et al., “Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections,” European Respiratory Journal, vol. 28, no. 4, pp. 695–702, 2006. View at Publisher · View at Google Scholar
  42. S. Gibot and F. Massin, “Soluble form of the triggering receptor expressed on myeloid cells 1: an anti-inflammatory mediator?” Intensive Care Medicine, vol. 32, no. 2, pp. 185–187, 2006. View at Publisher · View at Google Scholar
  43. N. R. Anthonisen, J. Manfreda, C. P. Warren, E. S. Hershfield, G. K. Harding, and N. A. Nelson, “Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease,” Annals of Internal Medicine, vol. 106, no. 2, pp. 196–204, 1987. View at Google Scholar
  44. J. R. Hurst, W. R. Perera, T. M. A. Wilkinson, G. C. Donaldson, and J. A. Wedzicha, “Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 1, pp. 71–78, 2006. View at Publisher · View at Google Scholar
  45. D. D. Sin and S. F. Paul Man, “Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease,” Circulation, vol. 107, no. 11, pp. 1514–1519, 2003. View at Publisher · View at Google Scholar
  46. D. M. Mannino, E. S. Ford, and S. C. Redd, “Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination,” The American Journal of Medicine, vol. 114, no. 9, pp. 758–762, 2003. View at Publisher · View at Google Scholar
  47. R. Broekhuizen, E. F. M. Wouters, E. C. Creutzberg, and A. M. W. J. Schols, “Raised CRP levels mark metabolic and functional impairment in advanced COPD,” Thorax, vol. 61, no. 1, pp. 17–22, 2006. View at Publisher · View at Google Scholar